Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retina horizontal cell | 6 studies | 84% ± 13% | |
| retinal ganglion cell | 6 studies | 86% ± 18% | |
| amacrine cell | 5 studies | 46% ± 24% | |
| OFF-bipolar cell | 3 studies | 73% ± 23% | |
| ON-bipolar cell | 3 studies | 68% ± 25% | |
| retinal cone cell | 3 studies | 34% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 4 studies | 39% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 99% | 1178.61 | 88 / 89 | 21% | 139.58 | 192 / 901 |
| brain | 75% | 2444.23 | 1977 / 2642 | 44% | 7.27 | 308 / 705 |
| bladder | 43% | 65.48 | 9 / 21 | 26% | 25.06 | 130 / 504 |
| breast | 9% | 17.10 | 40 / 459 | 42% | 50.48 | 475 / 1118 |
| spleen | 50% | 46.80 | 121 / 241 | 0% | 0 | 0 / 0 |
| ovary | 1% | 2.99 | 2 / 180 | 46% | 5.07 | 197 / 430 |
| muscle | 36% | 149.70 | 289 / 803 | 0% | 0 | 0 / 0 |
| lung | 12% | 9.63 | 72 / 578 | 19% | 1.89 | 219 / 1155 |
| thymus | 11% | 71.69 | 73 / 653 | 17% | 7.08 | 101 / 605 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 1.13 | 8 / 29 |
| liver | 20% | 15.27 | 46 / 226 | 4% | 0.39 | 17 / 406 |
| adrenal gland | 2% | 8.04 | 6 / 258 | 20% | 5.05 | 45 / 230 |
| peripheral blood | 14% | 12.71 | 134 / 929 | 0% | 0 | 0 / 0 |
| uterus | 4% | 2.32 | 6 / 170 | 11% | 2.73 | 50 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 1.11 | 6 / 45 |
| eye | 0% | 0 | 0 / 0 | 13% | 4.81 | 10 / 80 |
| pancreas | 0% | 0.38 | 1 / 328 | 10% | 2.41 | 18 / 178 |
| esophagus | 0% | 0.10 | 1 / 1445 | 5% | 0.41 | 10 / 183 |
| skin | 0% | 0.42 | 3 / 1809 | 5% | 1.89 | 25 / 472 |
| intestine | 0% | 0.80 | 4 / 966 | 2% | 0.08 | 11 / 527 |
| stomach | 0% | 0.24 | 1 / 359 | 2% | 0.08 | 6 / 286 |
| prostate | 0% | 0.32 | 1 / 245 | 1% | 0.03 | 5 / 502 |
| adipose | 0% | 0.31 | 5 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.19 | 4 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.13 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010467 | Biological process | gene expression |
| GO_0098976 | Biological process | excitatory chemical synaptic transmission |
| GO_0098977 | Biological process | inhibitory chemical synaptic transmission |
| GO_0030424 | Cellular component | axon |
| GO_0045202 | Cellular component | synapse |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | PVALB |
| Protein name | Parvalbumin Parvalbumin alpha |
| Synonyms | |
| Description | FUNCTION: In muscle, parvalbumin is thought to be involved in relaxation after contraction. It binds two calcium ions. FUNCTION: In muscle, parvalbumin is thought to be involved in relaxation after contraction. It binds two calcium ions. . FUNCTION: In muscle, parvalbumin is thought to be involved in relaxation after contraction. It binds two calcium ions. . FUNCTION: In muscle, parvalbumin is thought to be involved in relaxation after contraction. It binds two calcium ions. . |
| Accessions | H0Y3U0 ENST00000216200.9 ENST00000620986.3 B8ZZ19 ENST00000417718.7 ENST00000628345.1 ENST00000404171.1 ENST00000443735.1 B1AH72 ENST00000630974.1 P20472 ENST00000627445.2 ENST00000406910.6 ENST00000625893.2 |
